Dr Mehnaz Pervin is currently working as a Postdoctoral Researcher at the Baker Heart and Diabetes Institute, Melbourne, Australia. She received her PhD from the Department of Medicine, Monash University, Australia, in 2021, and completed her master’s degree in Applied Biochemistry from Konkuk University, South Korea. Her PhD research focused on investigating the post-translational modification of the glucocorticoid-induced leucine zipper (GILZ) protein, aiming to better target GILZ or GILZ-mediated processes in autoimmune and inflammatory diseases. She has published several papers in international journals. She is the recipient of several awards and scholarships, including the Academic Excellence Award from Konkuk University, the Brain Korea 21 Scholarship (BK21), and the Monash International Postgraduate Research Scholarship (MIPRS). At present, her research is directed towards investigating novel therapeutic approaches targeting the Nrf2/NLRP3 inflammasome axis to mitigate inflammation in cardiovascular and metabolic diseases.